The first biohybrid model of human ventricles has been used to answer a centuries-old question. Unlike other organs, the heart cannot repair itself after injury, so being able to engineer an entire ...

Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs ...

In cell culture, human cardiomyocytes significantly proliferate, and the total number cardiomyocytes increased by 30 percent when treated with follistatin as compared to the control groups. In an in ...